Thoratec Adds Sales Reps For Launch Of HeartMate II As Destination Therapy

Thoratec is beefing up its sales force to emphasize physician referrals now that FDA has approved its HeartMate II ventricular assist device as a "destination" therapy for patients who are not candidates for a heart transplant